Clinical evaluation of the PowerGlide Pro midline catheter- dwell time, complications and outcomes for various medications including prostaglandins.

Abstract

Purpose: The PowerGlide Pro™ Midline Catheter is a peripheral venous access device with a length of 8-10 cm, allowing the tip to reach far into the venous system. The aim of this study was to evaluate the dwell time of the catheter. Secondary endpoints included suitability for specific medications (e.g. prostaglandins) and assessment of complications.

Methods: Between January 2019 and November 2021, 50 patients were included in the study. Data on patient demographics, placement characteristics, complications and reasons for removal, were collected.

Results: Placement was technically successful in 92% (n = 46) of cases. In all cases, veins of the upper extremity were punctured (34 basilic veins, 7 brachial veins, 6 cephalic veins, and 3 median cubital veins). The average dwell time was 6.1 days (1-17 days). A significant difference between duration and medication administered could not be demonstrated.

Conclusions: The longer maximum dwell time compared to a standard peripheral venous catheter makes it particularly suitable for intravenous therapy for more than 7 days or patients who have poor peripheral vein status.